112 related articles for article (PubMed ID: 25919150)
1. A learning experience from price negotiations for vaccines.
Teerawattananon Y; Tritasavit N
Vaccine; 2015 May; 33 Suppl 1():A11-2. PubMed ID: 25919150
[No Abstract] [Full Text] [Related]
2. Global harmonisation in vaccine price.
Lancet Infect Dis; 2015 Mar; 15(3):249. PubMed ID: 25749216
[No Abstract] [Full Text] [Related]
3. First countries to be recipients of GAVI funds.
Maurice J
Bull World Health Organ; 2000; 78(12):1477-8. PubMed ID: 11196504
[No Abstract] [Full Text] [Related]
4. Immunizing the world.
Gates B; Gates M
Newsweek; 2000 Dec; 136(26A):72-3. PubMed ID: 11147309
[No Abstract] [Full Text] [Related]
5. Vaccines at what price?
Stephens DS; Ahmed R; Orenstein WA
Vaccine; 2014 Feb; 32(9):1029-30. PubMed ID: 24412350
[No Abstract] [Full Text] [Related]
6. Tiered pricing of vaccines: a win-win-win situation, not a subsidy.
Plahte J
Lancet Infect Dis; 2005 Jan; 5(1):58-63. PubMed ID: 15620562
[TBL] [Abstract][Full Text] [Related]
7. Progress report on the National Immunization Strategy.
Kondro W
CMAJ; 2007 Jun; 176(13):1811-3. PubMed ID: 17576972
[No Abstract] [Full Text] [Related]
8. The U.S. vaccine supply.
Hinman AR
N Engl J Med; 2005 Mar; 352(10):1046-7; author reply 1046-7. PubMed ID: 15758020
[No Abstract] [Full Text] [Related]
9. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
10. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
Brenzel L
Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
[TBL] [Abstract][Full Text] [Related]
11. USA faces chronic vaccine shortages.
Nelson R
Lancet Infect Dis; 2004 Feb; 4(2):66. PubMed ID: 14959757
[No Abstract] [Full Text] [Related]
12. [Vaccination in a developmental perspective].
Sommerfelt H; Godal T
Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2674-7. PubMed ID: 17057768
[No Abstract] [Full Text] [Related]
13. Global perspectives on vaccine financing.
Berman S; Giffin RB
Expert Rev Vaccines; 2004 Oct; 3(5):557-62. PubMed ID: 15485335
[TBL] [Abstract][Full Text] [Related]
14. [The Global Alliance helps children to fight diseases].
Stenson B
Lakartidningen; 2002 May; 99(19):2180-1. PubMed ID: 12082936
[No Abstract] [Full Text] [Related]
15. How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.
Mvundura M; Kien VD; Nga NT; Robertson J; Cuong NV; Tung HT; Hong DT; Levin C
Vaccine; 2014 Feb; 32(7):834-8. PubMed ID: 24370713
[TBL] [Abstract][Full Text] [Related]
16. Examining the cost of delivering routine immunization in Honduras.
Janusz CB; Castañeda-Orjuela C; Molina Aguilera IB; Felix Garcia AG; Mendoza L; Díaz IY; Resch SC
Vaccine; 2015 May; 33 Suppl 1():A53-9. PubMed ID: 25919175
[TBL] [Abstract][Full Text] [Related]
17. Vaccine network surprised by funding cut.
Eggertson L
CMAJ; 2005 Sep; 173(7):741-2. PubMed ID: 16186573
[No Abstract] [Full Text] [Related]
18. Regulating vaccines: can health-economics tools be used profitably?
Dhanasiri SK; Puliyel JM
Indian Pediatr; 2007 Jan; 44(1):11-4. PubMed ID: 17277425
[No Abstract] [Full Text] [Related]
19. Perspectives on the development and use of economic evidence for immunization decision-making in a developing country.
Molina-Aguilera IB
Vaccine; 2015 May; 33 Suppl 1():A6-7. PubMed ID: 25919176
[No Abstract] [Full Text] [Related]
20. Filling the vaccine gap.
Bonn D
Lancet Infect Dis; 2005 Jan; 5(1):7. PubMed ID: 15645540
[No Abstract] [Full Text] [Related]
[Next] [New Search]
